Patents by Inventor Christopher BANDORO

Christopher BANDORO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220241328
    Abstract: Provided herein are methods of transducing resting or non-activated T cells using CD8-targeted viral vectors.
    Type: Application
    Filed: January 10, 2022
    Publication date: August 4, 2022
    Applicant: Sana Biotechnology, Inc.
    Inventors: Christopher BANDORO, Patricia CRUITE, Kutlu ELPEK, Akinola Olumide EMMANUEL, Lauren Pepper MACKENZIE, Jagesh Vijaykumar SHAH, Kyle Marvin TRUDEAU
  • Publication number: 20210353543
    Abstract: Provided herein are lipid particles containing a lipid bilayer enclosing a lumen or cavity, a henipavirus F protein molecule or biologically active portion thereof, and a targeted envelope protein containing a henipavirus envelope attachment glycoprotein G (G protein) or biologically active portion thereof and a binding domain, such as a single domain antibody (sdAb) variable domain. Also provided herein are targeted envelope proteins containing a G protein fused or linked to a binding domain, such as a sdAb variable domain, and polynucleotides encoding such proteins. Also provided are producer cells and compositions containing such targeted lipid particles and methods of making and using the targeted lipid particles.
    Type: Application
    Filed: March 30, 2021
    Publication date: November 18, 2021
    Applicants: Sana Biotechnology, Inc., Flagship Pioneering Innovations V, Inc.
    Inventors: Kyle Marvin TRUDEAU, Christopher BANDORO, Lauren Pepper MACKENZIE, Jagesh Vijaykumar SHAH, Geoffrey A. VON MALTZAHN, Jacob Rosenblum RUBENS, Michael Travis MEE